Cargando…

On the relationship between tumour growth rate and survival in non-small cell lung cancer

A recurrent question within oncology drug development is predicting phase III outcome for a new treatment using early clinical data. One approach to tackle this problem has been to derive metrics from mathematical models that describe tumour size dynamics termed re-growth rate and time to tumour re-...

Descripción completa

Detalles Bibliográficos
Autor principal:	Mistry, Hitesh B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2017
Materias:	Mathematical Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712205/ https://www.ncbi.nlm.nih.gov/pubmed/29201573 http://dx.doi.org/10.7717/peerj.4111

Ejemplares similares

Complex versus simple models: ion-channel cardiac toxicity prediction
por: Mistry, Hitesh B.
Publicado: (2018)

A simple model of a growing tumour
por: Orrell, David, et al.
Publicado: (2019)

Resistance models to EGFR inhibition and chemotherapy in non-small cell lung cancer via analysis of tumour size dynamics
por: Mistry, Hitesh B., et al.
Publicado: (2019)

Predicting survival of pancreatic cancer patients treated with gemcitabine using longitudinal tumour size data
por: Wendling, Thierry, et al.
Publicado: (2016)

The relationship between aberrant methylation and survival in non-small-cell lung cancers
por: Toyooka, S, et al.
Publicado: (2004)

Relationship between vascularity, age and survival in non-small-cell lung cancer.
por: Chandrachud, L. M., et al.
Publicado: (1997)

Baseline tumour measurements predict survival in advanced non-small cell lung cancer
por: Gerber, D E, et al.
Publicado: (2013)

Epidermal growth factor receptor and notch signaling in non‐small‐cell lung cancer
por: Pancewicz‐Wojtkiewicz, Joanna
Publicado: (2016)

The Relationship between Patient Satisfaction with Service Quality and Survival in Non-Small Cell Lung Cancer – Is Self-Rated Health a Potential Confounder?
por: Lis, Christopher G., et al.
Publicado: (2015)

'Tumour volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC)
por: Jefferson, M. F., et al.
Publicado: (1996)

The relationship of EZH2 and HOXA5 with non-small cell lung carcinoma patient survival rate
por: Li, Yue, et al.
Publicado: (2020)

Relationship between weight gain and survival rate in patients with metastatic lung cancer
por: Fardad, Farshid, et al.
Publicado: (2021)

Relationship between survival and erythrocyte sedimentation rate in patients operated for lung cancer
por: Tekneci, Ahmet Kayahan, et al.
Publicado: (2022)

The tumour–stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients
por: Masuya, D, et al.
Publicado: (2004)

Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer
por: Ohri, Chandra M, et al.
Publicado: (2010)

The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival.
por: Veale, D., et al.
Publicado: (1993)

Nomogram for Predicting the Relationship between the Extent of Visceral Pleural Invasion and Survival in Non-Small-Cell Lung Cancer
por: Wang, Fan, et al.
Publicado: (2021)

Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells
por: Yamashita, Ryo, et al.
Publicado: (2015)

Radius additivity score: a novel combination index for tumour growth inhibition in fixed-dose xenograft studies
por: Melillo, Nicola, et al.
Publicado: (2023)

Relationship between obstructive lung disease and non-small cell lung cancer
por: Akamine, Takaki, et al.
Publicado: (2020)

The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer
por: Gujam, F J A, et al.
Publicado: (2015)

The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer
por: van Wyk, Hester C, et al.
Publicado: (2016)

Entrectinib for non-small cell lung cancer and solid tumours
Publicado: (2020)

Relation between the Serum E‐Selectin Level and the Survival Rate of Patients with Resected Non‐small Cell Lung Cancers
por: Tsumatori, Gentaro, et al.
Publicado: (1999)

Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.
por: Johnson, P. W., et al.
Publicado: (1993)

The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer
por: Vashi, Pankaj G., et al.
Publicado: (2015)

Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis
por: ten Berge, Deirdre M.H.J., et al.
Publicado: (2019)

Relationship between chemoresistance of lung tumours and cigarette smoking.
por: Volm, M., et al.
Publicado: (1990)

Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France.
por: Grosclaude, P., et al.
Publicado: (1995)

Codon 12 Ki-ras mutation in non-small-cell lung cancer: comparative evaluation in tumoural and non-tumoural lung.
por: Urban, T., et al.
Publicado: (1996)

Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer
por: Derman, B. A., et al.
Publicado: (2017)

The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
por: Sun, Yueqin, et al.
Publicado: (2021)

Quantitative relationship between volume of tumour cell units and their intravascular survival.
por: Lione, A., et al.
Publicado: (1978)

Model based analysis of the heterogeneity in the tumour size dynamics differentiates vemurafenib, dabrafenib and trametinib in metastatic melanoma
por: Mistry, Hitesh B., et al.
Publicado: (2017)

Vascular endothelial growth factor directly stimulates tumour cell proliferation in non-small cell lung cancer
por: DEVERY, AOIFE M., et al.
Publicado: (2015)

Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines
por: Martinez-Torres, Ana Carolina, et al.
Publicado: (2019)

Clinical significance of disseminated tumour cells in non-small cell lung cancer
por: Rud, A K, et al.
Publicado: (2013)

Relationship between Apparent Diffusion Coefficient and Tumour Cellularity in Lung Cancer
por: Chen, Lihua, et al.
Publicado: (2014)

Hypoxia Changes Energy Metabolism and Growth Rate in Non-Small Cell Lung Cancer Cells
por: Nisar, Hasan, et al.
Publicado: (2023)

ZNF703 Overexpression may act as an oncogene in non‐small cell lung cancer
por: Baykara, Onur, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_90u1u3gp6vpeaptie4daovafdp